Stevanato Group to Participate in Upcoming Investor Conferences
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will participate in two upcoming investor conferences.
- Tuesday, September 9, 2025, at 7:45 a.m. ET – The 23rd Annual Morgan Stanley Global Healthcare Conference in New York City
- Wednesday, September 24, 2025, at 10:45 a.m. BST – The Bank of America Global Healthcare Conference in London
A live webcast of each event will be available on the Company’s website at www.stevanatogroup.com under the “Investors” section. Replays will remain available for approximately 90 days after each event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation, and its engineering excellence are central to its ability to offer value-added solutions to clients.
For more information, please visit: www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250902701334/en/
Investor Relations
Lisa Miles
[email protected]
Media
Caterina Tripepi
[email protected]
KEYWORDS: Europe United States Italy North America
INDUSTRY KEYWORDS: Biotechnology General Health Other Health Health Pharmaceutical
MEDIA:
| Logo |
 |